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Abstract 
Background: To determine the validity of 
Pulsatility and Resistive index of trans-abdominal 
Doppler ultrasound(e-flow) in distinguishing 
between benign and malignant adnexal masses 
keeping histopathology as gold standard. 
Methods: In this cross sectional study  patients 
scheduled for elective surgery due to adenaxal  
masses were  included. All patients were 
sonographically evaluated for Pulsatility and 
Resistance indices aided with colour e-flow Doppler 
before the elective surgery of lesions. The 
performing radiologist had no information on the 
patients, to differentiate between benign and 
malignant adnexal masses based on Doppler indices. 
The final diagnoses were based on pathological and 
operative findings, keeping histopathology as gold 
standard.  
Results: Two hundred and twenty-nine patients 
were recruited out of which 18 were excluded, since 
the masses were finally not proven to be adnexal. Of 
the remaining 211 cases available for analysis, 163 
were benign and 48 were malignant. The sensitivity 
and specificity of the Pulsatility index for distinction 
were 89.57% and 85.42% and values for the 
Resistance index were 89.57% and 89.58% 
respectively. 
Conclusions: Pulsatility and resistance indices 
with trans-abdominal Doppler ultrasound (e-flow) 
have high accuracy in differentiating between 
benign and malignant adnexal masses. 
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To differentiate between benign and malignant 
adnexal masses is of great value as therapeutic 
approach is markedly different between the two 
entities. 1 Benign lesions like benign ovarian masses or 
functional changes need more conservative approach 
like either close observation or laparoscopic surgery, 
whereas malignant tumours require urgent 
laparotomy and in most of cases patient is being 
referred for further chemotherapy or radiotherapy by 
involving oncologists.2 Several attempts have been 
made to distinguish between the conditions in the past 
but with the availability of high-resolution ultrasound 
machines, colour doppler ultrasound is a possible 
technique for differentiation of benign from malignant 
adnexal masses as well as for early diagnosis of 
ovarian carcinoma for several years. 3,4 Some reports 
also showed the superiority of this technique in 
screening ovarian cancer while there are some other 
reports favouring its ability in differentiating benign 
from malignant tumours preoperatively.  5,6However, 
colour Doppler application in such previous reports 
was often needed via transvaginal approach and this 
might be inconvenient to some patients.  7 Currently, 
high-resolution colour Doppler with extended flow (e-
flow) has been developed, resulting in higher 
sensitivity in detection of blood flow in minute vessels 
even during trans abdominal examination.  
8,9Therefore, the purpose of the present study was to 
determine the sensitivity and specificity of Pulsatility 
index (PI) and resistance index (RI), derived from 
trans-abdominal colour Doppler e-flow, in 
differentiating benign from malignant ovarian 
tumours. 
Patients and Methods  
This  cross-sectional validation study  was done at 
Department of Gynecology and Radiology at Fauji 
Foundation Hospital Rawalpindi from January 2014 to 
December 2014.Two hundred and eleven patients of 
ovarian masses were included in the study with non-
probability purposive sampling. All patients referred 
by gynecologist with suspected ovarian mass for 
diagnostic workup and who are going to be operated 
from indoor and outdoor department were included in 
the study. Patients with disseminated disease and with 
severe co-morbid conditions and declared inoperable, 
patients with known diagnoses of ovarian malignancy 
which was scheduled for a second look operation and 
patients with past history of major pelvic surgery for 
non-ovarian pathological fibrosis or  vascular changes 
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were excluded from study.Doppler ultrasonography 
was performed using a Curvilinear probe of Aloka 
SSD 5500 in dimly lit room with comfortable 
temperature (22-24C) in supine position and Resistive 
and Pulsatility indices were calculated. Both Pulsatility 
index (PI) and resistance index (RI) were calculated. 
The value of each artery was calculated from a curve 
fitted to the average waveform over three cardiac 
cycles. The formulas used for PI and RI were PI = (S-
D)/ mean and RI = (S-D)/S respectively, when S is the 
peak Doppler frequency shift and D is the minimum. 
Signals from various areas within the tumour were 
determined but the lowest PI and RI were considered 
for data analysis. The area distribution of visualized 
vessels in the adnexal masses was also categorized and 
recorded as center of the mass, in the septum, in the 
papillae, at tumour wall or peri-tumor areas The final 
diagnosis as gold standard was based on either 
pathological findings or intraoperative findings in case 
of no pathological specimen. All of adnexal masses 
were divided into 2 groups as benign and malignant 
adnexal masses. The sensitivity and specificity of 
various cut-off levels of PI and RI were calculated and 
all data were analyzed using SPSS software version 
16.0. 
Resistive Index (RI) is calculated as  RI = [peak systolic 
velocity - end diastolic velocity]/peak systolic velocity. 
 Value should be less than 4 for malignant 
mass.Pulsatility Index (PI) is defined as the difference 
between the maximum flow and the minimum flow 
divided by the mean and value should be less than 1 
for malignant lesion. Lesions were categorized as 
simple cyst (anechoic with a thin wall and acoustic 
enhancement, with or without a single thin septations), 
dermoid cyst(fluid layer or echogenic mural nodule 
with shadowing), or an endometrioma (cyst with 
diffuse low-level echoes with one or two thin 
septations and a thin wall).Atypical features such as a 
thick wall or multiple irregular septations, lesions 
having nodules or solid elements.Histopathological 
features of malignant tumours include nuclear atypia 
and degree of mitoses (> 12 per 10 high-power fields) 
p53, BRCA1/2 genes and other genetic mutations, 
solid and cystic areas, extensive haemorrhage and 
necrosis and degree of micro-invasion. 
 
Results 
Between January 2014 to December 2014, 229 patients 
initially diagnosed as ovarian tumours were recruited 
to undergo e-flow colour trans-abdominal, doppler 
ultrasound examinations. Out of these eighteen 
patients were excluded because of pathological 
diagnoses of non-ovarian tumour including subserous 
myoma, hydrosalpinx and patients who lost follow up 
due to domestic reasons etc. The remaining 211 
patients were analyzed. Mean age (yrs) of 211 female 
patients was 45.29+10.51 with ranges from 20 to 80 
years.Histopathological examinations revealed 163 
patients (77.25%) having benign tumours and 48 
patients (22.75%) having malignant tumours.Out of 
211 patients, there were 151 patients who you were 
found benign (RI < 0.5) by doppler ultrasound, in 
which 146 patients were benign and 05 patients were 
found malignant histopathologically. Similarly, out of 
211 patients, there were 60 patients who you were 
found malignant (RI > 0.5) by doppler ultrasound, in 
which 17 patients were benign and 43 patients were 
found malignant histopathologically.  So the 
sensitivity, specificity, PPV and NPV of doppler 
ultrasound measurements (Resistive Index) was 
89.57%, 89.58%, 96.69%, 71.67% respectively (Table 1). 
 Out of 211 patients, there were 153 patients who  were 
found Benign (PI < 1) by doppler ultrasound, in which 
146patients were benign and 07 patients were found 
malignant histopathologically. Similarly, out of 211 
patients, there were 58 patients who were found 
malignant (PI > 1) by doppler ultrasound, in which 17 
patients were benign and 41 patients were found 
malignant histopathologically. Sensitivity, specificity, 
PPV and NPV of doppler ultrasound measurements 
(Pulsatility Index) was 89.57%, 85.42%, 95.42% 
and70.69% respectively(Table 2). 
 
Table 1:Doppler USG (Resistive Index) with 
Histopathology 





Benign 146 5 151 
Malignant 17 43 60 
Total 163 48 211 
Table 2:Doppler USG (Pulsatility Index) with 
Histopathology 






Benign 146 7 153 
Malignant 
17 41 58 
Total 163 48 211 
 
Discussion 
Ovarian pathology is 5th most common malignancy 
and is characterized by few early nonspecific 
symptoms and signs.10,11 The cure rate for disease at 
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early stage is 80-90 % and five-year relative survival 
rate for stage I is 95%.  12Ultrasound abdomen is 
considered the best initial imaging technique while CT 
and MRI also play a role in the minority of cases where 
ultrasound is inconclusive. The sonographic 
examination includes trans-abdominal and 
transvaginal scans combined with colour and pulsed 
doppler images. 13 The trans-abdominal scans, in 
comparison with transvaginal approach, also provide 
assessment of ascites, adenopathy, hydronephrosis, 
and liver metastases. On trans-vaginal studies, the 
field of view is much smaller compared to the field of 
view on trans-abdominal scans and it is also difficult 
to assess a mass high in pelvis. 14 Many centers are 
now using colour doppler in early assessment of 
ovarian mass. Combination of both morphology and 
doppler is more accurate than either used alone but 
there is no agreement as to which doppler index is best 
and at which level the threshold should be set to 
distinguish between high and low impedance flow.  15 
Considering the above mentioned limitations of trans-
abdominal and endo-vaginal ultrasound we used to 
see the validity of E-flow colour doppler indices 
(Pulsatility and Resistive index) for detection of 
malignancy in ovarian tumours which were referred to 
radiology department for evaluation.  
Differentiation of benign from malignant tumours is 
very important due to vast difference in mode of 
treatment and it might be achieved by several methods 
such as clinical signs and symptoms, serum CA 125 
levels, and ultrasound.16,17 Conventional ultrasound 
parameters for the differentiation of malignant from 
benign tumours are based merely on morphological 
features. The introduction of colour doppler 
ultrasound, especially high-resolution colour e-flow 
doppler with higher sensitivity in detection of blood 
flow in minute vessels, might allow a step forward 
from morphological to functional evaluation of the 
masses. The theoretical background comes from the 
observation that the new tumour vessels that grew as a 
result of angiogenesis differ from the normal vessels 
with respect to cellular composition, basement 
membrane structure and permeability. As a result, the 
haemodynamics of these vessels is changed. 18 
Considering angiogenesis as a neoplastic marker for 
malignancy, colour doppler ultrasound allows a better 
insight in the biological behaviour of the tumour and 
early diagnosis of cancer could become possible by 
detecting neo-vascularization in the tumour.19 In 
previous studies, some authors suggested the existence 
of clear cut-off points of PI and RI of benign and 
malignant tumours; Kurjak et al reported only one 
false positive and two false negative results in a 
screening program involving 624 benign ovarian 
tumours and 56 malignant tumours by using a cut-off 
value of RI 0.4. 20 Sengoku et al  reported sensitivity 
and specificity of 81.3% and 91.7% respectively when 
the cut- off value of PI 1.5 was used. 21 In the present 
study 54% of benign and 100% of malignant including 
borderline tumours had detectable arterial blood flow 
in the tumours using a colour doppler unit. This 
information may enable us to conclude that tumour 
without detectable blood flow is very unlikely to be 
malignant. Our cut-off PI value of 1.00, giving the 
sensitivity and specificity of 89.57% and 85.42%, 
respectively, was different from the study of Sengoku 
et al but was consistent with the data reported by 
Weiner et al.22 The scanning approach (trans-vaginal or 
trans-abdominal) and frequency of the probes might 
partially explain inconsistent results reported 
previously by different authors (Zanetta et al). 23 
Unlike previous reports in which they firstly used 
trans-abdominal probe and then trans-vaginal probe is 
performed if trans-abdominal examination was unable 
to visualize, our study with e-flow colour doppler we 
could identify the tumour in all cases. This may be the 
advantage of new high-resolution ultrasound 
technology permitting us avoiding the inconvenience 
of trans-vaginal approach. All authors agree that 
recognition of angiogenesis as a reference point for 
malignant changes within the ovary has proved to be a 
highly sensitive parameter.24 Neovascularization is an 
obligate event in malignant change. This recognition  
enables to observe the earliest stages in ovarian 
oncongenesis. The signs of neo-vascularization 
tumours, considered benign by conventional 
ultrasound, can  be missed by insufficient evaluation 
of the vascularity, whereas the tumours with suspicion 
of malignancy would be examined more thoroughly 
until the expected lowest PI and RI were found.25 It is 
important to examine all arterial signals to find out the 
lowest ones in each case to reduce the bias described. 
The present study pertinently cater for it.  
 
Conclusion 
1. Trans-abdominal e-flow colour Doppler indices are 
a useful tool in preoperative diagnosis of ovarian 
tumours.  
2.It is a objective sonological evaluation of the lesions 
and morphological features particularly those pointing 
to malignancy allows early detection and 
differentiation of benign and malignant tumours. 
Thus, it can help in timely referral of malignant cases 
to specialist care resulting in better outcome. 
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